Comparison of the efficiency of two short- term agonist protocols with conventional long protocol in women candidate Microinjection

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201310311760N26

Enrollment

150

Registered

2014-08-02

Start date

2014-05-15

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility associated with male factors. Female infertility associated with male factors

Interventions

Intervention 1: Control Groups: Standard protocol, for Down regulation, Triptorelin dose of 0.1 (to SC) from day 21 of the cycle begins.Continues until the day of HCG injection. Gonadotropins for s

Treatment - Drugs

Control Groups: Standard protocol, for Down regulation, Triptorelin dose of 0.1 (to SC) from day 21 of the cycle begins.Continues until the day of HCG injection. Gonadotropins for stimulate ovulat

Intervention Group1: Triptorelin dose of 0.1 (to SC) from day 21 of the cycle begins. Four day, gonadotropin injection stops.

Intervention Group2: Triptorelin dose of 0.1 (to SC) from day 21 of the cycle begins. First day, gonadotropin injection stops.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusio criteria: Healthy women 18 to 40 years; BMI = 20-32; Regular menstrual Exclusion criteria: Women PCOs; thyroid disorders, severe endometriosis, those with ovarian or uterine and ovarian pathology; FSH> 15 IU / LI on day 3 of the cycle; POOR RESPONSE; history of hyper stimulation in previous cycles; smokers; Abnormalities of the uterus, ovary-stimulating drugs or diet 2 months ago or the diet

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Laboratory.	—

Secondary

Measure	Time frame
The number of embryos. Timepoint: 14 the next day embryo transfer. Method of measurement: Ultrasound.;The number of high quality embryos. Timepoint: 14 the next day embryo transfer. Method of measurement: Ultrasound.;Total fertility/ET. Timepoint: 14 the next day embryo transfer. Method of measurement: Ultrasound.;The number of abortions performed. Timepoint: After 10 weeks of gestational sac formation. Method of measurement: clinical.;Consists of dominant follicles. Timepoint: 12 -16 day cycle. Method of measurement: Ultrasound.;Of the ampoules used per protocol. Timepoint: Duration of treatment. Method of measurement: clinical.	—

Measure

Time frame

The number of embryos. Timepoint: 14 the next day embryo transfer. Method of measurement: Ultrasound.;The number of high quality embryos. Timepoint: 14 the next day embryo transfer. Method of measurement: Ultrasound.;Total fertility/ET. Timepoint: 14 the next day embryo transfer. Method of measurement: Ultrasound.;The number of abortions performed. Timepoint: After 10 weeks of gestational sac formation. Method of measurement: clinical.;Consists of dominant follicles. Timepoint: 12 -16 day cycle. Method of measurement: Ultrasound.;Of the ampoules used per protocol. Timepoint: Duration of treatment. Method of measurement: clinical.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Poope A Rezaeian

Fatemehzahra Infertility & reproductive Health Reseach Center

persia_ph@yahoo.com+98 11 1227 4881

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026